11
Plasma half-life (min)
1,3
Biological half-life (hours)
1
Therapeutic indications
90–120 8–12 Adrenal insufficiency
replacement
80–120 8–12 Adrenal insufficiency
replacement
70–120 Not defined Duchenne muscular
dystrophy
60 12–36 Anti-inflammatory,
immunosuppressant;
Adrenal insufficiency
replacement
115–200 12–36 Anti-inflammatory,
immunosuppressant;
Adrenal insufficiency
replacement
30 12–36 Anti-inflammatory,
immunosuppressant
180 12–36 Anti-inflammatory,
immunosuppressant
200 36–72 Anti-inflammatory,
immunosuppressant;
Usually reserved for short-
term use in severe, acute
conditions.
300 36–72 Anti-inflammatory,
immunosuppressant;
Usually reserved for short-
term use in severe, acute
conditions.
